AR037594A1 - Metodos para tratar infecciones bacterianas en perros y gatos - Google Patents

Metodos para tratar infecciones bacterianas en perros y gatos

Info

Publication number
AR037594A1
AR037594A1 ARP020104593A ARP020104593A AR037594A1 AR 037594 A1 AR037594 A1 AR 037594A1 AR P020104593 A ARP020104593 A AR P020104593A AR P020104593 A ARP020104593 A AR P020104593A AR 037594 A1 AR037594 A1 AR 037594A1
Authority
AR
Argentina
Prior art keywords
cats
bacterial infections
dogs
methods
treat bacterial
Prior art date
Application number
ARP020104593A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR037594A1 publication Critical patent/AR037594A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ARP020104593A 2001-12-21 2002-11-28 Metodos para tratar infecciones bacterianas en perros y gatos AR037594A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26

Publications (1)

Publication Number Publication Date
AR037594A1 true AR037594A1 (es) 2004-11-17

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104593A AR037594A1 (es) 2001-12-21 2002-11-28 Metodos para tratar infecciones bacterianas en perros y gatos

Country Status (12)

Country Link
EP (1) EP1455900A1 (zh)
JP (1) JP2005524611A (zh)
CN (1) CN1606463A (zh)
AR (1) AR037594A1 (zh)
AU (1) AU2002348985A1 (zh)
BR (1) BR0215070A (zh)
CA (1) CA2470995A1 (zh)
IL (1) IL162103A0 (zh)
NO (1) NO20043008L (zh)
PL (1) PL370624A1 (zh)
TW (1) TW200301126A (zh)
WO (1) WO2003053522A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012215A (es) * 2004-04-22 2007-04-19 Pfizer Prod Inc Metodo de estabilizacion de la sal sodica cefovecina desordenada.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121745T3 (es) * 1989-03-30 1998-12-16 Pfizer Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas.
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
NO20043008L (no) 2004-09-01
EP1455900A1 (en) 2004-09-15
CA2470995A1 (en) 2003-07-03
BR0215070A (pt) 2004-11-09
WO2003053522A1 (en) 2003-07-03
CN1606463A (zh) 2005-04-13
PL370624A1 (en) 2005-05-30
AU2002348985A1 (en) 2003-07-09
TW200301126A (en) 2003-07-01
JP2005524611A (ja) 2005-08-18
IL162103A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
AR037595A1 (es) Metodos de tratamiento y formulaciones de cefalosporina
EA200501098A1 (ru) Антибактериальные агенты
EA199901015A1 (ru) 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
BR0214736A (pt) Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições
BR9915208A (pt) Preparado farmacêutico de moxifloxacina
EA200100623A1 (ru) Кетолидные антибиотики
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
BR9808290A (pt) Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação
DE60120752D1 (de) Verwendung von cyclopropancyclus enthaltenden carbonsäureverbindungen als medikament
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
PT1132392E (pt) Antibioticos cetolidos
NO923200D0 (no) Piperidin-derivater
FI933681A (fi) Antimikrobiellt medel
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
AR037594A1 (es) Metodos para tratar infecciones bacterianas en perros y gatos
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
ID22543A (id) Senyawa karbapenem, penggunaan dan senyawa antaranya
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
BR0308118A (pt) Método para o tratamento de osteoartrite
BR0110932A (pt) Alimento seco destinado alimentação dos cães e utilização do mesmo
EA200100444A1 (ru) Производные гигромицина а в качестве антибактериальных агентов

Legal Events

Date Code Title Description
FB Suspension of granting procedure